N. Ravenni

423 total citations
17 papers, 251 citations indexed

About

N. Ravenni is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Molecular Medicine. According to data from OpenAlex, N. Ravenni has authored 17 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Molecular Medicine. Recurrent topics in N. Ravenni's work include Cystic Fibrosis Research Advances (13 papers), Bacterial biofilms and quorum sensing (6 papers) and Antibiotic Resistance in Bacteria (5 papers). N. Ravenni is often cited by papers focused on Cystic Fibrosis Research Advances (13 papers), Bacterial biofilms and quorum sensing (6 papers) and Antibiotic Resistance in Bacteria (5 papers). N. Ravenni collaborates with scholars based in Italy, Germany and United Kingdom. N. Ravenni's co-authors include Giovanni Taccetti, Silvia Campana, Daniela Dolce, T. Repetto, Maurizio de Martino, Gerd Döring, Alessio Mengoni, S. Campana, Edoardo Pasolli and Federica Armanini and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Journal of Microbiological Methods and FEMS Microbiology Letters.

In The Last Decade

N. Ravenni

17 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Ravenni Italy 9 109 105 61 47 43 17 251
Daniela Dolce Italy 10 170 1.6× 209 2.0× 28 0.5× 56 1.2× 53 1.2× 31 365
James Lazenby United Kingdom 9 240 2.2× 45 0.4× 32 0.5× 87 1.9× 38 0.9× 16 384
Robson Souza Leão Brazil 12 171 1.6× 136 1.3× 45 0.7× 108 2.3× 64 1.5× 43 353
Pholawat Tingpej Thailand 10 293 2.7× 157 1.5× 30 0.5× 141 3.0× 41 1.0× 19 429
Blanca Gatti Argentina 8 66 0.6× 40 0.4× 32 0.5× 72 1.5× 37 0.9× 13 295
I. N. Simpson United Kingdom 11 98 0.9× 44 0.4× 66 1.1× 128 2.7× 33 0.8× 18 299
Helen L. Rose United Kingdom 4 60 0.6× 33 0.3× 34 0.6× 18 0.4× 26 0.6× 4 163
Indresh Singh United States 7 77 0.7× 34 0.3× 25 0.4× 84 1.8× 34 0.8× 10 211
Marisel R. Tuttobene Argentina 12 148 1.4× 21 0.2× 30 0.5× 200 4.3× 34 0.8× 34 313
Andrea G. Albarracín Orio Argentina 8 74 0.7× 20 0.2× 30 0.5× 88 1.9× 28 0.7× 14 239

Countries citing papers authored by N. Ravenni

Since Specialization
Citations

This map shows the geographic impact of N. Ravenni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Ravenni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Ravenni more than expected).

Fields of papers citing papers by N. Ravenni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Ravenni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Ravenni. The network helps show where N. Ravenni may publish in the future.

Co-authorship network of co-authors of N. Ravenni

This figure shows the co-authorship network connecting the top 25 collaborators of N. Ravenni. A scholar is included among the top collaborators of N. Ravenni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Ravenni. N. Ravenni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pepe, Angela, Daniela Dolce, Silvia Campana, et al.. (2025). Elexacaftor/tezacaftor/ivacaftor and inflammation in children and adolescents with cystic fibrosis: a retrospective dual-center cohort study. Therapeutic Advances in Respiratory Disease. 19. 2703894034–2703894034. 3 indexed citations
2.
Taccetti, Giovanni, Vito Terlizzi, Silvia Campana, et al.. (2024). Antibiotic treatment of bacterial lung infections in cystic fibrosis. European Journal of Pediatrics. 184(1). 82–82. 1 indexed citations
3.
Francalanci, Michela, Vito Terlizzi, Anna Silvia Neri, et al.. (2023). Nutritional Status and Circulating Levels of Fat-Soluble Vitamins in Cystic Fibrosis Patients: A Cohort Study and Evaluation of the Effect of CFTR Modulators. Children. 10(2). 252–252. 20 indexed citations
4.
5.
Manara, Serena, Edoardo Pasolli, Daniela Dolce, et al.. (2018). Whole-genome epidemiology, characterisation, and phylogenetic reconstruction of Staphylococcus aureus strains in a paediatric hospital. Genome Medicine. 10(1). 82–82. 57 indexed citations
6.
Maggini, Valentina, Giovanna Pesavento, Isabel Maida, et al.. (2017). Exploring the Effect of the Composition of Three Different Oregano Essential Oils on the Growth of Multidrug-Resistant Cystic Fibrosis Pseudomonas aeruginosa Strains. Natural Product Communications. 12(12). 4 indexed citations
7.
Pesavento, Giovanna, Valentina Maggini, Isabel Maida, et al.. (2016). Essential Oil from Origanum vulgare Completely Inhibits the Growth of Multidrug-Resistant Cystic Fibrosis Pathogens. Natural Product Communications. 11(6). 861–4. 16 indexed citations
8.
Dolce, Daniela, et al.. (2014). 121 Anti-Pseudomonas aeruginosa antibodies and microbiological outcome in not chronically infected patients. Journal of Cystic Fibrosis. 13. S77–S77. 1 indexed citations
9.
Taccetti, Giovanni, Lisa Cariani, N. Ravenni, et al.. (2010). Epidemiology of first/new Pseudomonas aeruginosa infection in cystic fibrosis patients. Journal of Cystic Fibrosis. 9. S29–S29. 6 indexed citations
10.
Ferri, Lorenzo, Elena Perrin, S. Campana, et al.. (2010). Application of multiplex single nucleotide primer extension (mSNuPE) to the identification of bacteria: The Burkholderia cepacia complex case. Journal of Microbiological Methods. 80(3). 251–256. 13 indexed citations
11.
MacDonald, Daniel W., Leah Cuthbertson, S. Campana, et al.. (2010). Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?. Journal of Antimicrobial Chemotherapy. 65(11). 2373–2375. 17 indexed citations
12.
Tabacchioni, Silvia, Lorenzo Ferri, G. Manno, et al.. (2008). Use of the gyrB gene to discriminate among species of the Burkholderia cepacia complex. FEMS Microbiology Letters. 281(2). 175–182. 21 indexed citations
13.
Festini, Filippo, Giovanni Taccetti, Silvia Campana, et al.. (2007). Patient risk of contact with respiratory pathogens from inanimate surfaces in a cystic fibrosis outpatient clinic. A prospective study over a four‐year period. Pediatric Pulmonology. 42(9). 779–784. 4 indexed citations
14.
Herasimenka, Yury, Paola Cescutti, Giuseppe Impallomeni, et al.. (2006). Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex. Journal of Cystic Fibrosis. 6(2). 145–152. 23 indexed citations
15.
Festini, Filippo, et al.. (2005). 428 Pain in children and adults with cystic fibrosis: a comparative study. Journal of Cystic Fibrosis. 4. S114–S114. 1 indexed citations
16.
Campana, Silvia, Giovanni Taccetti, N. Ravenni, et al.. (2004). Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center. Journal of Cystic Fibrosis. 3(3). 159–163. 51 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Dolce Breakdown of academic impact, for papers by James Lazenby Breakdown of academic impact, for papers by Robson Souza Leão Breakdown of academic impact, for papers by Pholawat Tingpej Breakdown of academic impact, for papers by Blanca Gatti Breakdown of academic impact, for papers by I. N. Simpson Breakdown of academic impact, for papers by Helen L. Rose Breakdown of academic impact, for papers by Indresh Singh Breakdown of academic impact, for papers by Marisel R. Tuttobene Breakdown of academic impact, for papers by Andrea G. Albarracín Orio
Rankless by CCL
2026